Dupha Formulations (India) Private Limited
About Dupha Formulations (India) Private Limited
Data last updated:
Dupha Formulations (India) Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 25 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U02423MP2005PTC017897.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Anupama Madan and Aruna Singh.
Its last annual general meeting (AGM) was held on 22 April 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at A – 1/16 Mig Iind Mahanandanagar, Ujjain, Madhya Pradesh, India – 456001.
As per the financials filed for FY 2019, the company reported a revenue of ₹27,000. For the same year it recorded a net loss of ₹1.17 Lakh (net margin -434.7%) and EBITDA of ₹26,643 (EBITDA margin 98.7%). Revenue has declined at a compounded annual rate (CAGR) of 84% over three years and 67% over five years.
As per MCA filings, the company has satisfied charges of ₹25 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Dupha Formulations (India) Private Limited's registered office is in Ujjain, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1/16 Mig Iind Mahanandanagar, Ujjain, Madhya Pradesh, India – 456001
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Dupha Formulations (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dupha Formulations (India) is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
Financials of Dupha Formulations (India) Private Limited
FY 2019 filings availableDupha Formulations (India) Private Limited reported revenue of ₹27,000 for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 67% over five years. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26,643 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98.7% | ||||
| Net Profit Margin | -434.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dupha Formulations (India) Private Limited, buy the company report.
Board of directors of Dupha Formulations (India) Private Limited
Dupha Formulations (India) has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupama Madan | Director | 25 Aug 2005 | 21 Years 2 Months | Current |
| Aruna Singh | Director | 25 Aug 2005 | 21 Years 2 Months | Current |
| Viny Lahiri | Director | 25 Aug 2005 | 21 Years 2 Months | Current |
| Rajesh Singh Also directs: Cure & Care Drugs Private Limited | Director | 25 Aug 2005 | 21 Years 2 Months | Current |
| Deepak Singh Rathore | Director | 25 Aug 2005 | 21 Years 2 Months | Current |
Auditor
Dupha Formulations (India) Private Limited is audited by Subhash Soni & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Subhash Soni & Associates | FY 2017 | 007303C |
Shareholding
The shareholding of Dupha Formulations (India) Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Dupha Formulations (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2007 | 10064985 | Uco Bank | ₹25 Lakh | Satisfied |
To see the full charge records of Dupha Formulations (India) Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dupha Formulations (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dupha Formulations (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dupha Formulations (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dupha Formulations (India) Private Limited has 6 board changes on record since 2005: 5 appointments and 1 cessation. The latest: Rajesh Singh ceased to be Director on 30 Sep 2022.
Frequently asked questions
Dupha Formulations (India) is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 25 August 2005 (21+ years old) and is registered under CIN U02423MP2005PTC017897.
Dupha Formulations (India) has 5 current directors:
- Anupama Madan - Director
- Aruna Singh - Director
- Viny Lahiri - Director
- Rajesh Singh - Director
- Deepak Singh Rathore - Director
The latest financial statements of Dupha Formulations (India) on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 22 April 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Dupha Formulations (India) is U02423MP2005PTC017897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dupha Formulations (India) was incorporated on 25 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Gwalior.
Rajesh Singh ceased to be Director on 30 Sep 2022. Anupama Madan was appointed as Director on 25 Aug 2005. Aruna Singh was appointed as Director on 25 Aug 2005. Dupha Formulations (India) has 6 board changes on record in total.
The registered office of Dupha Formulations (India) is at A – 116 Mig Iind Mahanandanagar, Ujjain, Madhya Pradesh, India – 456001.
Dupha Formulations (India) operates in the healthcare industry, in the other hospital and medical care activities segment.
Dupha Formulations (India) has no open charges and satisfied charges of ₹25 Lakh as per latest MCA filings.
The compliance status of Dupha Formulations (India) is active non-compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
